Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (141-150 of 178) with videos related to

Pageof 18
Sort By:
Angewandte Chemie (International Ed. in English)|October 12, 2022
Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated ResistanceTian Lan, Uday S Ganapathy, Sachin Sharma, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessusUday S Ganapathy, Rubén González Del Río, Mónica Cacho-Izquierdo, et al.
Plos One|November 5, 2010
Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stressesMai Ping Tan, Patricia Sequeira, Wen Wei Lin, et al.
Plos One|August 13, 2013
Exploring the mode of action of bioactive compounds by microfluidic transcriptional profiling in mycobacteriaPaul Murima, Paola Florez de Sessions, Vivian Lim, et al.
The FEBS Journal|October 26, 2011
Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazolesMeera Gurumurthy, Tathagata Mukherjee, Cynthia S Dowd, et al.
Nature Communications|April 5, 2020
Pyrazinamide triggers degradation of its target aspartate decarboxylasePooja Gopal, Jickky Palmae Sarathy, Michelle Yee, et al.
The Journal of Experimental Medicine|July 19, 2018
Impact of immunopathology on the antituberculous activity of pyrazinamideLandry Blanc, Jansy Passiflora Sarathy, Nadine Alvarez Cabrera, et al.
Journal of Medicinal Chemistry|February 13, 2009
Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationshipsPilho Kim, Sunhee Kang, Helena I Boshoff, et al.
ACS Infectious Diseases|June 2, 2026
Cytochrome P450-Mediated Metabolism of Antimycobacterial <i>N</i>α-Aroyl-<i>N</i>-aryl-phenylalanine AmidesJohannes Doering, Erik Meerz, Rüdiger W Seidel, et al.
Scientific Reports|November 16, 2019
Disrupting coupling within mycobacterial F-ATP synthases subunit ε causes dysregulated energy production and cell wall biosynthesisWuan-Geok Saw, Mu-Lu Wu, Priya Ragunathan, et al.
Pageof 18

Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Angewandte Chemie (International Ed. in English)|October 12, 2022
Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated ResistanceTian Lan, Uday S Ganapathy, Sachin Sharma, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessusUday S Ganapathy, Rubén González Del Río, Mónica Cacho-Izquierdo, et al.
Plos One|November 5, 2010
Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stressesMai Ping Tan, Patricia Sequeira, Wen Wei Lin, et al.
Plos One|August 13, 2013
Exploring the mode of action of bioactive compounds by microfluidic transcriptional profiling in mycobacteriaPaul Murima, Paola Florez de Sessions, Vivian Lim, et al.
The FEBS Journal|October 26, 2011
Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazolesMeera Gurumurthy, Tathagata Mukherjee, Cynthia S Dowd, et al.
Nature Communications|April 5, 2020
Pyrazinamide triggers degradation of its target aspartate decarboxylasePooja Gopal, Jickky Palmae Sarathy, Michelle Yee, et al.
The Journal of Experimental Medicine|July 19, 2018
Impact of immunopathology on the antituberculous activity of pyrazinamideLandry Blanc, Jansy Passiflora Sarathy, Nadine Alvarez Cabrera, et al.
Journal of Medicinal Chemistry|February 13, 2009
Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationshipsPilho Kim, Sunhee Kang, Helena I Boshoff, et al.
ACS Infectious Diseases|June 2, 2026
Cytochrome P450-Mediated Metabolism of Antimycobacterial <i>N</i>α-Aroyl-<i>N</i>-aryl-phenylalanine AmidesJohannes Doering, Erik Meerz, Rüdiger W Seidel, et al.
Scientific Reports|November 16, 2019
Disrupting coupling within mycobacterial F-ATP synthases subunit ε causes dysregulated energy production and cell wall biosynthesisWuan-Geok Saw, Mu-Lu Wu, Priya Ragunathan, et al.
Pageof 18